After passing through Valencia and Alicante, the Longevity World Forum strengthens it’s international presence and confirms Madrid as host city for 2026. The fourth edition continues to offer a hybrid format, combining in-person and virtual formats offering all benefits of attending a conference while allowing participants to join from anywhere in the world.
This pioneering longevity congress in Europe is designed for individuals with scientific, business, social, or economic interests, whether they are healthcare professionals and researchers, industry companies, emerging E-Health startups, students, or anyone with a keen interest in the field from anywhere across the world.
News! The fourth edition of LWF Will be held in Madrid in 2026. The Spanish capital Will allow the congress to strengthen its role as a hub for the scientific community, the innovation ecosystem, and the industry linked to the sector. A step forward for a project that, in this edition, will add a dedicated days for startups.
It allows to attend all the programmed activities and share networking spaces with agents of the sector and scientific-medical professionals, among other referents in the field of medical longevity.
Platform that allows the interconnection between people and live broadcasting with a live streaming that will show in real time what happens in the congress.
It makes it possible to follow the presentation of the event with presentations, round tables, interviews or statements of speakers and people of interest.
The scientist and technologist who participated in the 2024 edition are internationally renowned experts in key fields related to human longevity.
The third edition of the Longevity World Forum focused on three pillars…
It will bring together biotechnology executives, institutions, academics, and researchers to better understand the scientific and biological basis of aging, aiding the development of new strategies and therapeutic targets.
It will bring together the IT, biotech, and pharmaceutical industry, through Startups, investors, and industry executives to transfer research results to the enterprise, explore opportunities, market strategies, and create the new disruptive business models within aging.
It will bring together the IT, biotech, and pharmaceutical industry, through Startups, investors, and industry executives to transfer research results to the enterprise, explore opportunities, market strategies, and create the new disruptive business models within aging.